Invivyd (IVVD) Capital Expenditures Growth (3y) (2024 - 2025)
Invivyd (IVVD) Capital Expenditures Growth (3y) (2024 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.11 Bn | 1,785.05 Bn | - | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 3 | BeOne Medicines | 473.57 Bn | 468.78 Bn | 1.35 Bn | -12.25% |
| 4 | Vertex Pharmaceuticals | 123.78 Bn | 116.54 Bn | 2.59 Bn | 46.88% |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.98 Bn | 3.31 Bn | 8.97% |
| 6 | Belite Bio | 62.12 Bn | 62.12 Bn | - | - |
| 7 | Argenx Se | 54.64 Bn | 49.45 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 38.05 Bn | 35.05 Bn | 959.66 Mn | 16.27% |
| 9 | Revolution Medicines | 36.28 Bn | 36.28 Bn | - | - |
| 10 | Invivyd | 102.42 Mn | -124.27 Mn | 16.07 Mn | -66.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -66.26% |
| Sep 30, 2025 | 45.86% |
| Jun 30, 2025 | -28.65% |
| Mar 31, 2025 | 85.16% |
| Dec 31, 2024 | -26.02% |